Overview

Irritation and Sensitization Study of d-Amphetamine Transdermal System

Status:
Completed
Trial end date:
2020-05-16
Target enrollment:
Participant gender:
Summary
The study will assess skin irritation as well as sensitization for d-ATS patch in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Noven Therapeutics
Treatments:
Amphetamine
Dextroamphetamine